Debt and equity are ready to fund MOB and HRE deals, BOMA panelists agree
By John B. Mugford
The “Capital Markets” panel discussion during the BOMA Medical Real Estate Conference April 30 included (from left to right): Joe Magliochettiof Remedy Medical Properties, Jon Lewin of MedCraft, moderator Brannan Knott of CBRE, Peter Volas of Cleveland Clinic and Aashik Rao of Fengate Asset Management. (Photo courtesy of BOMA)
If anything has changed dramatically in the healthcare real estate (HRE) transactions market during the past year or so, it’s that there’s plenty more debt and equity available for investors.
Here’s an example of how much things have changed.
In fall 2025, Chicago-based Remedy Medical Properties, in a joint venture (JV) partnership with Kayne Anderson Real Estate, announced a deal to acquire an 18 million square foot medical outpatient building (MOB) portfolio from Welltower Inc. (NYSE: WELL) for $7.2 billion. As the Remedy-Kayne team set about trying to assemble about $4 billion in debt to pull off what would be the largest MOB deal in history, Joe Magliochetti, Remedy’s chief investment officer, said they had one big question:
“Does that level of liquidity even exist … for medical office buildings in the market?”
As it turned out, the answer was a resounding, “Yes.”
“It’s interesting to be where we are today,” Mr. Magliochetti said during an April 30 panel discussion at the recent BOMA International 2026 Medical Real Estate Conference held at the Hilton Bayfront Hotel in San Diego.
“I know we’re going to talk more about this – about the level of liquidity there is in the market,” he continued. “That liquidity, debt and equity liquidity, a year ago, some of that was less available than it is today, though you could tell it was improving…
“One of the things that was a critical ingredient in this transaction was
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE
